GT Biopharma raises $6.5M in registered direct offering of shares and warrants at $1.00 per unit

GT Biopharma, Inc.

Offering of 6.5M shares or pre-funded warrants plus 6.5M warrants to purchase common stock.
Gross proceeds of $6.5 million, before placement agent fees and expenses.
Warrants exercisable at $1.00 per share, beginning six months after issuance, for five years.
H.C. Wainwright & Co. acted as exclusive placement agent; cash fee of $390,000 paid.
Net proceeds to be used for general corporate purposes; closing expected January 4, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.